CRIS Q4 2020 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-8.0% YoY

Gross Profit

$3M95.0% margin

Operating Income

-$6M-207.5% margin

Net Income

-$8M-248.6% margin

EPS (Diluted)

$-2.27

QoQ Revenue Growth

+10.3%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$865,000

Balance Sheet

Total Assets

$204M

Total Liabilities

$74M

Stockholders' Equity

$131M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-8.0%
Gross Profit	$3M	$3M	-8.1%
Operating Income	-$6M	-$7M	+14.4%
Net Income	-$8M	-$9M	+12.7%

Revenue Segments

Other Revenue

$3,000

Contra Revenue

-$22,000